Atrial Fibrillation: In Search for the Optimal Target for Rate Control

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT07135258

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07135258
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Hong Kong SAR China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07135258. Randomized; triple masking; primary purpose treatment. Start 2025-10-01 (anticipated); primary completion 2027-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atrial Fibrillation: In Search for the Optimal Target for Rate Control
Acronym
STRICT-4-FUN
Condition
Atrial Fibrillation (Permanent)
Condition
Atrial Fibrillation (AF)
Intervention (Drug)
Ivabradine + Usual Care
Intervention (Drug)
Placebo + usual care
Lead sponsor
The University of Hong Kong (class: other)

Record details

Record id
cardio:ct-nct07135258
Content hash
896c9987f77913f9a714b81b28d4bdf54720aba5b7b109d9c09a9d35073d9520